# CannaLnx Broadens Insured Medical Cannabis Access Across California > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/insured-medical-cannabis-access-california-expansion/ > **Published:** 2026-04-14T07:01:34-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:22:24-04:00 > **Clinical Summary:** CannaLnx expands insured medical cannabis access across California with new retail and delivery partners, improving patient access and coverage. --- ✦ New CED Clinical Relevance  #76Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic CannalnxExpandsInsuredMedical Why This Matters This item covers developments relevant to [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) and clinical practice. Clinicians monitoring evidence in this area should review the source material. Clinical Summary Summary not available. See source for full context. Dr. Caplan’s Take “This is a development worth tracking. The clinical implications will become clearer as more evidence accumulates.” Clinical Perspective 🧠 Clinicians should review this item in the context of their current practice and patient population. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20CannaLnx%20Expands%20Insured%20Medical%20Cannabis%20Access%20Across%20California%20with%209%20Retail...%20%40drcaplan&url=https%3A//www.businesswire.com/news/home/20260414197062/en/CannaLnx-Expands-Insured-Medical-Cannabis-Access-Across-California-with-9-Retail-and-Delivery-Partners)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.businesswire.com/news/home/20260414197062/en/CannaLnx-Expands-Insured-Medical-Cannabis-Access-Across-California-with-9-Retail-and-Delivery-Partners)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20CannaLnx%20Expands%20Insured%20Medical%20Cannabis%20Access%20Across%20California%20with%209%20Retail...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.businesswire.com/news/home/20260414197062/en/CannaLnx-Expands-Insured-Medical-Cannabis-Access-Across-California-with-9-Retail-and-Delivery-Partners)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.businesswire.com/news/home/20260414197062/en/CannaLnx-Expands-Insured-Medical-Cannabis-Access-Across-California-with-9-Retail-and-Delivery-Partners](https://www.businesswire.com/news/home/20260414197062/en/CannaLnx-Expands-Insured-Medical-Cannabis-Access-Across-California-with-9-Retail-and-Delivery-Partners) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Medical Cannabis Significantly Reduced Use of Opioids and Other Rx Drugs](https://cedclinic.com/medical-cannabis-opioid-alternatives-reduce-rx-drug-use/) Explore how [medical cannabis access](https://cedclinic.com/medical-marijuana-card-reciprocity/) can reduce reliance on opioids and other prescription medications, highlighting clinical benefits. [Learn More](https://cedclinic.com/medical-cannabis-opioid-alternatives-reduce-rx-drug-use/) [Idaho Medical Cannabis Advocates Say They Have Collected 100000 Signatures](https://cedclinic.com/idaho-medical-cannabis-signatures-100000-collected/) Read about advocacy efforts expanding [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) access in Idaho, reflecting growing patient demand and policy change. [Read More](https://cedclinic.com/idaho-medical-cannabis-signatures-100000-collected/) [Canify AG CATHAROS Launches: Germany's Local Marketplace for Medical Cannabis](https://cedclinic.com/germany-medical-cannabis-marketplace-launch/) Discover Germany’s new [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) marketplace, enhancing [patient access](https://cedclinic.com/iowa-medical-cannabis-dispensaries-expansion/) and supporting insured cannabis distribution. [Explore Now](https://cedclinic.com/germany-medical-cannabis-marketplace-launch/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).